Why Making Dramatic Moves: TTM Technologies Inc. (NASDAQ:TTMI), Ophthotech Corporation (NASDAQ:OPHT), Grana y Montero SAA (ADR) (NYSE:GRAM), Aviva plc (NYSE:AV), Novavax (NASDAQ:NVAX)

TTM Technologies Inc. (NASDAQ:TTMI) reported net sales for the second quarter of 2015 were $445.4 million compared to $329.2 million in the first quarter of 2015 and $297.6 million in the second quarter of 2014. GAAP operating income for the second quarter of 2015 was a loss of $7.1 million compared to GAAP operating income of $8.3 million in the first quarter of 2015 and $3.2 million in the second quarter of 2014. TTM Technologies Inc. (NASDAQ:TTMI) belongs to Technology sector. Its net profit margin is 1.60% and weekly performance is -15.77%. On last trading day company shares ended up $7.69. TTM Technologies Inc. (NASDAQ:TTMI) distance from 50-day simple moving average (SMA50) is -21.94%.

Ophthotech Corporation (NASDAQ:OPHT) reported Collaboration revenue was $1.6 million for the quarter ended June 30, 2015. For the six months ended June 30, 2015, collaboration revenue was $43.3 million and primarily related to the $50.0 million enrollment-based milestone that was achieved in March 2015 under Ophthotech’s agreement with Novartis. The balance of the milestone was recorded as deferred revenue. The Company did not have any collaboration revenue in the comparable periods in 2014. Ophthotech Corporation (NASDAQ:OPHT) shares decreased -11.33% in last trading session and ended the day at $55.09. Its return on assets is -18.40%. Ophthotech Corporation (NASDAQ:OPHT) quarterly performance is 13.45%.

On 07 August, Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced the appointment of Jeffrey W. Henderson to its board of directors. Henderson brings nearly 30 years of financial, commercial and pharmaceutical industry expertise to the board, most recently serving for almost 10 years as chief financial officer of $100-billion health care products and services company, Cardinal Health. Halozyme Therapeutics, Inc. (NASDAQ:HALO) belongs to Healthcare sector. Its net profit margin is -69.50% and weekly performance is -9.51%. On last trading day company shares ended up $21.12. Halozyme Therapeutics, Inc. (NASDAQ:HALO) distance from 50-day simple moving average (SMA50) is -3.32%.

Aviva plc (NYSE:AV) reported a 9 percent increase in first-half profit, boosted by its life business. Operating profit rose to 1.2 billion pounds ($1.8 billion) from 1.1 billion pounds a year earlier, Aviva said in a statement on Thursday. The London-based insurer also increased its interim dividend by 15 percent to 6.75 pence. Aviva plc (NYSE:AV) ended the last trading day at $16.42. Company weekly volatility is calculated as 0.84%. Aviva plc (NYSE:AV) showed a weekly performance of 0.18%.

Novavax, Inc. (NASDAQ:NVAX) announced that Stanley C. Erck, President and CEO, will present at the Wedbush PacGrow Healthcare Conference on Wednesday, August 12, 2015 at 12:45 p.m. US Eastern Time, Le Parker Meridian hotel, New York City. Novavax, Inc. (NASDAQ:NVAX) belongs to Healthcare sector. Its weekly performance is -10.20%. On last trading day company shares ended up $10.83. Novavax, Inc. (NASDAQ:NVAX) distance from 50-day simple moving average (SMA50) is 0.89%.

Leave a Reply

Your email address will not be published. Required fields are marked *